Wider inclusion criteria needed for thrombolytic therapy.

Wider inclusion criteria needed for thrombolytic therapy.

Bibliografische gegevens
Hoofdauteurs:	Peto, R, Collins, R, Sleight, P
Formaat:	Journal article
Taal:	English
Gepubliceerd in:	1989

Gelijkaardige items

The risk of stroke after thrombolytic therapy.
door: Collins, R, et al.
Gepubliceerd in: (1992)

ISIS-3 SHOWS SIMILAR RESULTS WITH DIFFERENT THROMBOLYTIC AGENTS
door: Peto, R
Gepubliceerd in: (1991)

Understanding the wider needs of children with disabilities
door: Maria Zuurmond
Gepubliceerd in: (2013-05-01)

Aspirin, heparin, and fibrinolytic therapy in suspected acute myocardial infarction.
door: Collins, R, et al.
Gepubliceerd in: (1997)

Thrombolytic Therapy in Acute Stroke
door: Yen-Wei Hsu, et al.
Gepubliceerd in: (2008-09-01)

Thrombolytic therapy for ischemic stroke
door: Natalia Vyacheslavovna Pizova
Gepubliceerd in: (2013-11-01)

THROMBOLYTIC THERAPY OF ACUTE MYOCARDIAL INFARCTION
door: D. P. Sementsov
Gepubliceerd in: (2015-12-01)

THROMBOLYTIC THERAPY OF ACUTE MYOCARDIAL INFARCTION
door: D. P. Sementsov
Gepubliceerd in: (2015-12-01)

Studies needed on wider spread in colder weather
door: Chung, Clarissa
Gepubliceerd in: (2020)

Space Physics: The Need for a Wider Perspective
door: Mats André
Gepubliceerd in: (2022-06-01)

THROMBOLYTIC THERAPY IN PATIENTS WITH MYOCARDIAL INFARCTION
door: G. P. Ishmurzin, et al.
Gepubliceerd in: (2010-12-01)

The Impact of the Fibrinolytic System on the Outcomes of Thrombolytic Therapy
door: R. E. Kalinin, et al.
Gepubliceerd in: (2025-01-01)

Aspect of Thrombolytic Therapy: A Review
door: Md. Ramjan Ali, et al.
Gepubliceerd in: (2014-01-01)

Thrombolytic therapy in submassive pulmonary embolism
door: Eda Özlek, et al.
Gepubliceerd in: (2017-03-01)

Building Resilience Against Disinformation : Need for Wider Education
door: Neubronner, Stephanie
Gepubliceerd in: (2018)

Mechanisms of artemisinin action and resistance: wider focus is needed.
door: Woodrow, C, et al.
Gepubliceerd in: (2011)

”Film Studies Always Need the Wider Approach of Intermediality.”
door: Pethő Ágnes
Gepubliceerd in: (2018-10-01)

EVOLUTION OF THROMBOLYTIC THERAPY IN THE TREATMENT OF MYOCARDIAL INFARCTION
door: P. G. Kesov, et al.
Gepubliceerd in: (2015-09-01)

EVOLUTION OF THROMBOLYTIC THERAPY IN THE TREATMENT OF MYOCARDIAL INFARCTION
door: P. G. Kesov, et al.
Gepubliceerd in: (2015-09-01)

Systemic Thrombolytic Therapy for Ischemic Stroke in the Course of Anticoagulants
door: L. Kh.-B. Akhmatkhanova, et al.
Gepubliceerd in: (2021-11-01)

Outcome of sub-massive pulmonary thromboemboli in patients who received thrombolytic and or non-thrombolytic therapy
door: Hasan Allah Sadeghi, et al.
Gepubliceerd in: (2016-01-01)

ISIS-2 - A LARGE RANDOMIZED TRIAL OF INTRAVENOUS STREPTOKINASE AND ORAL ASPIRIN IN ACUTE MYOCARDIAL-INFARCTION
door: Collins, R, et al.
Gepubliceerd in: (1989)

Significant reduction in mortality with streptokinase given 7-24 hours after pain onset.
door: Collins, R, et al.
Gepubliceerd in: (1988)

ISIS-4 - REPLY
door: Collins, R, et al.
Gepubliceerd in: (1995)

OVERVIEW OF MORTALITY RESULTS FROM ALL RANDOMIZED CONTROLLED TRIALS OF EARLY IV BETA-BLOCKADE AFTER MYOCARDIAL-INFARCTION
door: Sleight, P, et al.
Gepubliceerd in: (1986)

Effects of cholesterol-lowering therapy and antioxidant vitamin supplementation on the risk of stroke
door: Collins, R, et al.
Gepubliceerd in: (2002)

Quality of life of elderly ischaemic stroke patients one year after thrombolytic therapy. A comparison between patients with and without thrombolytic therapy
door: de Weerd Leonie, et al.
Gepubliceerd in: (2012-07-01)

Thrombolytic therapy in patients with ischemic stroke in the vertebrobasilar system
door: K V Anisimov, et al.
Gepubliceerd in: (2012-09-01)

THROMBOLYTIC THERAPY IN PATIENTS WITH ACUTE MYOCARDIAL INFARCTION
door: E. V. Konstantinova, et al.
Gepubliceerd in: (2016-01-01)

Modeling the outcomes of thrombolytic therapy in ischemic stroke
door: Yuliya D. Minina, et al.
Gepubliceerd in: (2022-12-01)

Thrombolytic therapy for central venous catheter occlusion
door: Jacquelyn L. Baskin, et al.
Gepubliceerd in: (2012-05-01)

Update on Thrombolytic Therapy in Acute Pulmonary Thromboembolism
door: Elif Yilmazel Ucar
Gepubliceerd in: (2019-06-01)

Pulmonary alveolar hemorrhage following thrombolytic therapy
door: Narayanan S, et al.
Gepubliceerd in: (2017-04-01)

Intravenous Thrombolytic Therapy in Acute Ischemic Stroke
door: Semai Bek, et al.
Gepubliceerd in: (2009-12-01)

Thrombolytic therapy for acute stroke: The hidden dimension.
door: Ossama eMansour, et al.
Gepubliceerd in: (2010-09-01)

COMPLICATIONS OF THROMBOLYTIC THERAPY IN ACTUAL CLINICAL PRACTICE
door: A. F. Sharafutdinova, et al.
Gepubliceerd in: (2014-07-01)

COMPLICATIONS OF THROMBOLYTIC THERAPY IN ACTUAL CLINICAL PRACTICE
door: A. F. Sharafutdinova, et al.
Gepubliceerd in: (2014-07-01)

Intravenous thrombolytic therapy in myocardial infarction (review)
door: I I Staroverov
Gepubliceerd in: (2003-10-01)

Thrombolytic therapy in acute myocardial infarction at prehospital stage
door: A P Golikov, et al.
Gepubliceerd in: (2004-01-01)

Overview of randomized trials of intravenous heparin in patients with acute myocardial infarction treated with thrombolytic therapy.
door: Mahaffey, K, et al.
Gepubliceerd in: (1996)